Kern Capital has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Personal Genome Diagnostics's $100M Series B+ round in February 2021, alongside Windham Venture Partners, Vensana Capital, Sands Capital Ventures and 6 others. That company is in Health and bio.

What Kern Capital invests in

• Health and bio · 1 · 100%
• Data and analytics · 1 · 100%

How Kern Capital invests

Share is of the 1 round on Recent Funding that name Kern Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Kern Capital portfolio companies

• PPersonal Genome Diagnostics$100MSeries B+ · Feb 2021

Most frequent co-investors

• NNEA1 shared round · last Feb 1, 2021
• IInnovatus Capital Partners1 shared round · last Feb 1, 2021
• RRock Springs Capital1 shared round · last Feb 1, 2021
• SSands Capital Ventures1 shared round · last Feb 1, 2021
• WWindham Venture Partners1 shared round · last Feb 1, 2021
• VVensana Capital1 shared round · last Feb 1, 2021
• CCowen Healthcare Investments1 shared round · last Feb 1, 2021
• PPFM Health Sciences1 shared round · last Feb 1, 2021
• NNorthpond Ventures1 shared round · last Feb 1, 2021

Similar investors

• 221501 company · 1 deal in 12 mo
• CCove Hill Partners1 company · 1 deal in 12 mo
• DDSW Ventures1 company · 1 deal in 12 mo
• NNorth Bridge Venture Partners & Growth Equity1 company
• CCastrum Capital2 companies · 2 deals in 12 mo
• SSelah Ventures2 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Kern Capital, which is a subset of its real portfolio. API: /api/v1/investors/kern-capital (get a free API key). More: the most active VC firms and new venture capital funds.